NFE2L2 and Hepatic steatosis: Through PDGF-bR/NLRP3/caspase1 pathway to reduce liver inflammation, and exerts antitumor effects by inducing apoptosis and autophagy in hepatocellular carcinoma, and inhibition of hepatic steatosis by activating the Nrf2 signaling pathway